The U.S. Food and Drug Administration granted emergency use authorization for nitenpyram, a medication to treat New World screwworm infestations in dogs and cats. It is the first generic animal drug ...
Cronus Pharma Introduces Pimobendan Chewable Tablets (First FDA-Approved Generic) for Veterinary Use
EAST BRUNSWICK, N.J., June 09, 2026--(BUSINESS WIRE)--Cronus Pharma LLC, a leader in animal health innovation, is excited to announce the release of its new Pimobendan Chewable Tablets, available for ...
Tech pro ThioJoe analyzes whether using Windows generic keys is legal, risky, or somewhere in between. Watch: Mob thrashes and strips Dum Dum TMC councillor over 'theft of relief material' GK: Which ...
The Trump administration on Monday said it is adding generic medications to its direct-to-consumer drug sales website, TrumpRx. The platform, which launched in February, is key to his administration's ...
The International Finance Corporation mobilizes private capital at scale, supports businesses from microenterprises to large corporations, and creates jobs that drive economic growth and reduce ...
Over the last several years, Apple has dramatically improved how it handles lithium-ion battery charging in iPhones, iPads, Macs, and Apple Watches. Across multiple system releases, the company moved ...
Using AI chatbots for even just 10 minutes may have a shockingly negative impact on people’s ability to think and problem-solve, according to a new study from researchers at Carnegie Mellon, MIT, ...
Here’s how to invest in custom visuals and turn that content into years of stronger engagement, trust and brand differentiation. Custom visual content builds trust faster by showing real people, ...
The era of cheap, officially approved semaglutide is finally here—in Canada, that is. The country has just become the first in North America and the first G7 nation to license a generic version of the ...
Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results